Company news

Biomerica, Inc. news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Diagnostics Industry Leader Gary Huff Appointed to Biomerica Strategic Advisory Board

February 20, 2024

Biomerica Reports Second Quarter 2024 Financial Results

January 15, 2024

Biomerica Received US FDA 510(k) Clearance for Their Hp Detect™ ELISA Test Product Designed to Detect the Presence of the H. pylori Bacteria That infects Approximately 35% of the U.S. Population

December 17, 2023

Biomerica Expands inFoods IBS Reach with Addition of Several New GI Groups

November 7, 2023

Biomerica Reports First Quarter 2024 Financial Results

October 12, 2023

Diagnostics Industry Leader Jack Kenny Joins Biomerica’s Board of Directors

August 27, 2023

Biomerica Reports Fiscal 2023 Year End Results

August 24, 2023

Biomerica’s inFoods® IBS test is now available at Gastro Health, providing a revolutionary new treatment for patients suffering from Irritable Bowel Syndrome (IBS).

April 16, 2023

Biomerica Reports Q3 Fiscal 2023 Results

April 13, 2023

Biomerica announces the Launch of InFoods IBS as a Laboratory Developed Test (LDT); First patient samples have been processed

March 7, 2023

Biomerica Announces Closing of $8 Million Underwritten Public Offering of Common Stock

March 6, 2023

Biomerica Announces Pricing of $8 Million Underwritten Public Offering of Common Stock

March 2, 2023

Biomerica Announces Proposed Underwritten Public Offering of Common Stock

March 1, 2023

Biomerica Reports Financial Results for Fiscal 2023 Second Quarter Ended November 30, 2022

January 12, 2023

Biomerica Appoints Mayo Clinic Gastroenterologist, Dr. Brian E. Lacy, to the Company’s Scientific Advisory Board

January 9, 2023

Biomerica Receives KFDA and Ministry of Health Approval for Colorectal Screening and Breast Screening Tests in Saudi Arabia and UAE

December 7, 2022

Biomerica’s Aware® Breast Self Exam and EZ Detect™ Colon Disease Test Now Available on Amazon and Fulfilled by Amazon

September 28, 2022

Biomerica Plans Launch of InFoods® IBS Test; Names Robert Carlson as Chief Commercial Officer

August 29, 2022

Biomerica Reports Fiscal 2022 Year End Results

August 28, 2022

Biomerica Announces CE Mark for Its H. pylori Diagnostic Test, hp+detect™

May 11, 2022

Biomerica Announces FDA Submission For a Test to Detect Helicobacter pylori (H. pylori), a Bacteria That Infects Approximately 35% of the US Population

April 25, 2022

Biomerica Reports 111% Increase in Q3 Fiscal 2022 Revenues to $7.6 million vs. Q3 Fiscal 2021

April 13, 2022

Biomerica Announces Positive Topline Results from the Endpoint Clinical Trial of its InFoods® IBS Treatment for Patients with Irritable Bowel Syndrome

February 7, 2022

Biomerica Reports Record Financial Results for Fiscal Second Quarter ended November 30, 2021

January 12, 2022

Biomerica Announces Preliminary Second Quarter Revenue Increase of Approximately 238%, to Approximately $4.6 Million

December 15, 2021

Biomerica Forms Scientific Advisory Board for Colorectal Cancer Screening

November 18, 2021

Biomerica Receives Notice of Allowance from Canadian Patent Office for Patent Covering Irritable Bowel Syndrome (IBS) Food Sensitivity Testing & Treatment

November 3, 2021

Biomerica Launches New Website for Its Aware® Breast Exam Device

October 28, 2021

Biomerica Reports Results for Fiscal First Quarter ended August 31, 2021

October 14, 2021

Biomerica Reports Fiscal 2021 Year End Results

August 26, 2021

Biomerica Announces Notice of Allowance for Patent on Product used to Diagnose and Treat Depression

August 10, 2021

Biomerica Launches New Website For Its EZ Detect™ Colorectal Disease Screening Test

August 4, 2021

Biomerica Signs Exclusive Distribution Agreement in Canada for its New and Proprietary Helicobacter Pylori (H. pylori) Test, hp+detect™

June 23, 2021

Biomerica Receives Notice of Allowance from Mexican Patent Office for Irritable Bowel Syndrome Food Sensitivity Testing & Treatment

June 14, 2021

Biomerica’s Fast 15-Minute Easy to Use COVID-19 Antigen Test Now Available With Simple Nasal Swab

May 10, 2021

Biomerica Reports 208% Increase In Q3 Fiscal 2021 Sales, Over Q3 Fiscal 2020

April 14, 2021

Biomerica Reports Fiscal 2021 Second Quarter Financial Results and Provides Business Update

January 14, 2021

Biomerica’s Fast 15-Minute Simple to Use Covid-19 Antigen Rapid Test Receives CE Mark

January 11, 2021

Biomerica Reports Fiscal 2021 1st Quarter Financial Results

October 15, 2020

Biomerica Reports Fiscal Year End May 31, 2020 Financial Results

August 31, 2020

Biomerica Announces Retirement of Chief Financial Officer (CFO), hiring of new CFO and appointment of new member to the Board of Directors

August 30, 2020

Biomerica Announces Notice of Allowance for New U.S. Patent Application Covering Diagnostic Guided Therapy for Irritable Bowel Syndrome (IBS) and Provides Progress Update on COVID-19 antibody tests

August 11, 2020

Biomerica Announces Filing of New Three Year Shelf Registration Statement

July 21, 2020

Biomerica files for FDA Emergency Use Authorization (EUA) of its Unique Laboratory Antibody Test for COVID-19

June 15, 2020

Biomerica Receives CE mark for New High-Volume Version of 10 Minute Test for COVID-19 Exposure and Expands International Distribution

May 6, 2020

Biomerica Announces Third Quarter Financial Results

April 14, 2020

Biomerica Signs Two Definitive Agreements with Mount Sinai Medical School in New York to Scale-up a Laboratory Version Serological Test for COVID-19 That Enables High-Volume Screenings in Labs

April 1, 2020

Biomerica Begins Shipping Samples of 10 Minute Test for COVID-19 Virus Exposure

March 16, 2020

Biomerica Announces $2.0 Million Investment by Palm Global Small Cap Master Fund

February 25, 2020

Biomerica Announces Second Quarter Financial Results; Sales Up 6.4% for the Quarter

January 14, 2020

← Newer news releases · Older news releases →

Decks

The 5 newest of 19 decks. Every deck is listed under its year.